Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

1.

Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins.

Lamon-Fava S, Diffenderfer MR, Barrett PH, Buchsbaum A, Nyaku M, Horvath KV, Asztalos BF, Otokozawa S, Ai M, Matthan NR, Lichtenstein AH, Dolnikowski GG, Schaefer EJ.

Arterioscler Thromb Vasc Biol. 2008 Sep;28(9):1672-8. doi: 10.1161/ATVBAHA.108.164541. Epub 2008 Jun 19.

PMID:
18566298
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Effects of torcetrapib in patients at high risk for coronary events.

Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, Lopez-Sendon J, Mosca L, Tardif JC, Waters DD, Shear CL, Revkin JH, Buhr KA, Fisher MR, Tall AR, Brewer B; ILLUMINATE Investigators.

N Engl J Med. 2007 Nov 22;357(21):2109-22. Epub 2007 Nov 5.

PMID:
17984165
[PubMed - indexed for MEDLINE]
Free Article
3.

Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial.

Bots ML, Visseren FL, Evans GW, Riley WA, Revkin JH, Tegeler CH, Shear CL, Duggan WT, Vicari RM, Grobbee DE, Kastelein JJ; RADIANCE 2 Investigators.

Lancet. 2007 Jul 14;370(9582):153-60.

PMID:
17630038
[PubMed - indexed for MEDLINE]
4.

Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia.

Kastelein JJ, van Leuven SI, Burgess L, Evans GW, Kuivenhoven JA, Barter PJ, Revkin JH, Grobbee DE, Riley WA, Shear CL, Duggan WT, Bots ML; RADIANCE 1 Investigators.

N Engl J Med. 2007 Apr 19;356(16):1620-30. Epub 2007 Mar 26.

PMID:
17387131
[PubMed - indexed for MEDLINE]
Free Article
5.

Effect of torcetrapib on the progression of coronary atherosclerosis.

Nissen SE, Tardif JC, Nicholls SJ, Revkin JH, Shear CL, Duggan WT, Ruzyllo W, Bachinsky WB, Lasala GP, Tuzcu EM; ILLUSTRATE Investigators.

N Engl J Med. 2007 Mar 29;356(13):1304-16. Epub 2007 Mar 26. Erratum in: N Engl J Med. 2007 Aug 23;357(8):835. Lasala, Gregory P [corrected to Lasala, Gabriel P].

PMID:
17387129
[PubMed - indexed for MEDLINE]
Free Article
6.

Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.

El Harchaoui K, van der Steeg WA, Stroes ES, Kuivenhoven JA, Otvos JD, Wareham NJ, Hutten BA, Kastelein JJ, Khaw KT, Boekholdt SM.

J Am Coll Cardiol. 2007 Feb 6;49(5):547-53. Epub 2007 Jan 22.

PMID:
17276177
[PubMed - indexed for MEDLINE]
Free Article
7.

The failure of torcetrapib: was it the molecule or the mechanism?

Tall AR, Yvan-Charvet L, Wang N.

Arterioscler Thromb Vasc Biol. 2007 Feb;27(2):257-60. No abstract available.

PMID:
17229967
[PubMed - indexed for MEDLINE]
Free Article
8.

Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy.

Jeyarajah EJ, Cromwell WC, Otvos JD.

Clin Lab Med. 2006 Dec;26(4):847-70. Review.

PMID:
17110242
[PubMed - indexed for MEDLINE]
9.

The effect of 24 months of combination statin and extended-release niacin on carotid intima-media thickness: ARBITER 3.

Taylor AJ, Lee HJ, Sullenberger LE.

Curr Med Res Opin. 2006 Nov;22(11):2243-50.

PMID:
17076985
[PubMed - indexed for MEDLINE]
10.

Relationship between the concentration and antiatherogenic activity of high-density lipoproteins.

Barter PJ, Rye KA.

Curr Opin Lipidol. 2006 Aug;17(4):399-403. Review.

PMID:
16832163
[PubMed - indexed for MEDLINE]
11.

Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?

Cuchel M, Rader DJ.

Circulation. 2006 May 30;113(21):2548-55. Review. No abstract available.

PMID:
16735689
[PubMed - indexed for MEDLINE]
Free Article
12.

Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.

Otvos JD, Collins D, Freedman DS, Shalaurova I, Schaefer EJ, McNamara JR, Bloomfield HE, Robins SJ.

Circulation. 2006 Mar 28;113(12):1556-63. Epub 2006 Mar 13.

PMID:
16534013
[PubMed - indexed for MEDLINE]
Free Article
13.

Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome.

Szapary PO, Bloedon LT, Samaha FF, Duffy D, Wolfe ML, Soffer D, Reilly MP, Chittams J, Rader DJ.

Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):182-8. Epub 2005 Nov 10.

PMID:
16284192
[PubMed - indexed for MEDLINE]
Free Article
14.

Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial.

Asztalos BF, Collins D, Cupples LA, Demissie S, Horvath KV, Bloomfield HE, Robins SJ, Schaefer EJ.

Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2185-91. Epub 2005 Aug 25.

PMID:
16123324
[PubMed - indexed for MEDLINE]
Free Article
15.

Characterization of determinants of ligand binding to the nicotinic acid receptor GPR109A (HM74A/PUMA-G).

Tunaru S, L├Ąttig J, Kero J, Krause G, Offermanns S.

Mol Pharmacol. 2005 Nov;68(5):1271-80. Epub 2005 Aug 11.

PMID:
16099840
[PubMed - indexed for MEDLINE]
Free Article
16.

Current Drug Options for Raising HDL Cholesterol.

Dunbar RL, Rader DJ.

Curr Treat Options Cardiovasc Med. 2005 May;7(1):15-23.

PMID:
15913500
[PubMed - as supplied by publisher]
17.

Influence of extended-release nicotinic acid on nonesterified fatty acid flux in the metabolic syndrome with atherogenic dyslipidemia.

Vega GL, Cater NB, Meguro S, Grundy SM.

Am J Cardiol. 2005 Jun 1;95(11):1309-13.

PMID:
15904634
[PubMed - indexed for MEDLINE]
18.

The effects of niacin on lipoprotein subclass distribution.

Morgan JM, Carey CM, Lincoff A, Capuzzi DM.

Prev Cardiol. 2004 Fall;7(4):182-7; quiz 188. Review.

PMID:
15539965
[PubMed - indexed for MEDLINE]
19.

Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins.

Taylor AJ, Sullenberger LE, Lee HJ, Lee JK, Grace KA.

Circulation. 2004 Dec 7;110(23):3512-7. Epub 2004 Nov 10. Erratum in: Circulation. 2004 Dec 7;110(23):3615. Circulation. 2005 Jun 21;111(24):e446.

PMID:
15537681
[PubMed - indexed for MEDLINE]
Free Article
20.

Niacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cells.

Ganji SH, Tavintharan S, Zhu D, Xing Y, Kamanna VS, Kashyap ML.

J Lipid Res. 2004 Oct;45(10):1835-45. Epub 2004 Jul 16.

PMID:
15258194
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk